Trial · NCT00371033
Results by group22
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 22
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Decrease in the NIH-CPSI Total Score by at Least 6 Points | 1-Pregabalin | 103 | Participants | ||
| Decrease in the NIH-CPSI Total Score by at Least 6 Points | 2-Placebo | 38 | Participants | ||
| Subscales of the NIH-CPSI | 1-Pregabalin | Total score | 19.7 | Standard Deviation 8.5 | units on the NIH-CPSI scale |
| Subscales of the NIH-CPSI | 2-Placebo | Total score | 21.6 | Standard Deviation 8.9 | units on the NIH-CPSI scale |
| Subscales of the NIH-CPSI | 1-Pregabalin | Pain domain score | 9.1 | Standard Deviation 3.1 | units on the NIH-CPSI scale |
| Subscales of the NIH-CPSI | 2-Placebo | Pain domain score | 10.1 | Standard Deviation 4.7 | units on the NIH-CPSI scale |
| Subscales of the NIH-CPSI | 1-Pregabalin | Urinary symptoms domain score | 3.7 | Standard Deviation 2.6 | units on the NIH-CPSI scale |
| Subscales of the NIH-CPSI | 2-Placebo | Urinary symptoms domain score | 4.0 | Standard Deviation 2.7 | units on the NIH-CPSI scale |
| Subscales of the NIH-CPSI | 1-Pregabalin | Quality of life domain | 6.9 | Standard Deviation 2.9 | units on the NIH-CPSI scale |
| Subscales of the NIH-CPSI | 2-Placebo | Quality of life domain | 7.4 | Standard Deviation 3.1 | units on the NIH-CPSI scale |
| Moderately or Markedly Improve on Global Response Assessment (GRA) | 1-Pregabalin | 68 | Participants | ||
| Moderately or Markedly Improve on Global Response Assessment (GRA) | 2-Placebo | 20 | Participants | ||
| Hospital Anxiety & Depression Scale | 1-Pregabalin | 12.4 | Standard Deviation 7.8 | units on a scale | |
| Hospital Anxiety & Depression Scale | 2-Placebo | 12.2 | Standard Deviation 7.8 | units on a scale | |
| McGill Pain Questionnaire | 1-Pregabalin | 9.6 | Standard Deviation 8.8 | units on a scale | |
| McGill Pain Questionnaire | 2-Placebo | 12.4 | Standard Deviation 9.1 | units on a scale | |
| Medical Outcomes Study Short Form 12 | 1-Pregabalin | Physical [PCS] Component Summary | 46.9 | Standard Deviation 10.1 | units on a scale |
| Medical Outcomes Study Short Form 12 | 2-Placebo | Physical [PCS] Component Summary | 44.3 | Standard Deviation 10.6 | units on a scale |
| Medical Outcomes Study Short Form 12 | 1-Pregabalin | Mental [MCS] Component Summary | 45.0 | Standard Deviation 11.2 | units on a scale |
| Medical Outcomes Study Short Form 12 | 2-Placebo | Mental [MCS] Component Summary | 44.6 | Standard Deviation 10.6 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00371033/results